Sofosbuvir and Daclatasvir Therapy for Recurrent Hepatitis C after Liver Transplantation

Trial Profile

Sofosbuvir and Daclatasvir Therapy for Recurrent Hepatitis C after Liver Transplantation

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 28 Aug 2015

At a glance

  • Drugs Daclatasvir (Primary) ; Sofosbuvir (Primary)
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Aug 2015 New trial record
    • 14 Jul 2015 Results published in the BMJ Case Reports.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top